FCM
BHVN icon

Fieldview Capital Management’s Biohaven BHVN Stock Holding History

Fieldview Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,510
Closed -$691K – 420
2024
Q4 		$691K Buy
+18,510
New +$864K 0.11% 245

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Fieldview Capital Management's BHVN Position: Q1 2025 in Review

Fieldview Capital Management sold out of Biohaven (BHVN) in Q1 2025, closing a stake of 18,510 shares — an estimated $691K sold.

Fieldview Capital Management first reported a position in BHVN in Q4 2024 and held it in 1 quarter. The position peaked at $691K in Q4 2024. 266 funds tracked by Wall St. Rank hold BHVN as of Q1 2025.

  • Fieldview Capital Management reported no remaining Biohaven position as of Q1 2025 after selling out during the quarter.
  • Fieldview Capital Management sold 18,510 Biohaven shares in Q1 2025, an estimated $691K.
  • Fieldview Capital Management first reported a position in Biohaven in Q4 2024 and held it in 1 quarter.
  • Fieldview Capital Management's Biohaven position peaked at $691K in Q4 2024.
  • 266 funds tracked by Wall St. Rank held Biohaven as of Q1 2025.

Based on Fieldview Capital Management's 13F filing for Q1 2025, filed 15 May 2025.